The landscape of biotechnology investing is often a dramatic interplay of clinical breakthroughs and regulatory hurdles, a reality vividly illustrated by Capricor Therapeutics' remarkable 439.4% stock surge following its promising clinical trial results for a new Duchenne muscular dystrophy
With over 200 pharmacies closing across Ohio in 2024, many rural communities are becoming “pharmacy deserts,” leaving residents without access to essential medications and care. At the forefront of this crisis is Emily Eddy, a pharmacy professor at Ohio Northern University and a newly appointed fel
A class of drugs once quietly confined to the clinical management of diabetes has forcefully breached the walls of traditional healthcare, creating a multi-billion dollar cultural and commercial phenomenon that is reshaping the pharmaceutical landscape. Glucagon-like peptide-1 (GLP-1) receptor
With over 250 million people living with chronic hepatitis B, the prospect of a "functional cure" has long been a distant goal. Now, with recent pivotal study results for a new therapy, that goal appears closer than ever. We sit down with Faisal Zain, a leading expert in medical
Today we're speaking with Faisal Zain, a leading expert in medical technology. While his work often focuses on the cutting-edge devices used in diagnostics and treatment, he brings a unique perspective on how sweeping federal health policy changes impact the very real, on-the-ground ability of
A foundational pillar of American public health, the universal childhood immunization schedule, has been abruptly dismantled, igniting a fierce debate over the safety of the nation's children and the integrity of the institutions designed to protect them. This decision has created an
